MIR548A1: A Potential Drug Target Or Biomarker (G693125)

Target Name: MIR548A1

NCBI ID: G693125

MIR548A1

Other Name(s): hsa-miR-548a-3p | MicroRNA 548a-1 | hsa-mir-548a-1 | microRNA 548a-1 | MIRN548A1

MIR548A1: A Potential Drug Target Or Biomarker

MIR548A1 (hsa-miR-548a-3p) is a non-coding RNA molecule that has been identified as a potential drug target or biomarker for several diseases, including cancer. Its unique structure and expression patterns make it an attractive candidate for further research.

MIR548A1 is a microRNA (miRNA), a small non-coding RNA molecule that plays a crucial role in post-transcriptional gene regulation. miRNAs are made from a pool of non-coding RNAs, called exons, that are spliced together to form a functional RNA molecule. They are involved in a variety of cellular processes, including cell growth, differentiation, and apoptosis.

MIR548A1 is a part of the hsa-miR-548 cluster of miRNAs, which are known for their involvement in insulin sensitivity and glucose metabolism. This cluster includes several other miRNAs, includinghsa-miR-548b, hsa-miR-548c, and hsa-miR-548d. These miRNAs are expressed in different tissues and have been implicated in a variety of physiological processes, including insulin sensitivity, glucose metabolism, and inflammation.

One of the key features of MIR548A1 is its unique structure. It is a single exon molecule that contains a unique 5' end with a conserved G/Crichardson base, a 3' end with a conserved A/Grichardson base, and a middle region with a single AUG codon. This structure is unique among miRNAs and has been implicated in its ability to interact with target RNAs.

MIR548A1 has been shown to have a variety of functions in different cellular contexts. For example, it has been shown to be involved in insulin sensitivity and glucose metabolism by regulating the activity of several key enzymes involved in these processes. It has also been shown to play a role in cell apoptosis, which is the process by which cells die when they are no longer needed.

In addition to its potential functions, MIR548A1 is also a good candidate for drug targeting. Its unique structure and expression patterns make it a potential target for small molecules or antibodies that can modulate its activity. This has the potential to lead to new treatments for a variety of diseases, including cancer.

Overall, MIR548A1 is a promising candidate for drug targeting or biomarker research. Further studies are needed to fully understand its functions and potential as a drug target.

Protein Name: MicroRNA 548a-1

The "MIR548A1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR548A1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets